Here we present a CRISPR/Cas9 gene editing method to introduce the PD LRRK2 G2019S monogenic mutation in marmoset embryonic (Cj-ESC) and induced pluripotent (Cj-iPSCs) stem cells. This evidence concerns the gene LRRK2 and Parkinson disease.